Foresee Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Foresee Pharmaceuticals has a total shareholder equity of NT$1.0B and total debt of NT$200.0M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are NT$1.6B and NT$593.1M respectively.
Key information
20.0%
Debt to equity ratio
NT$200.00m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$972.76m |
| Equity | NT$1.00b |
| Total liabilities | NT$593.11m |
| Total assets | NT$1.59b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6576's short term assets (NT$1.3B) exceed its short term liabilities (NT$500.4M).
Long Term Liabilities: 6576's short term assets (NT$1.3B) exceed its long term liabilities (NT$92.7M).
Debt to Equity History and Analysis
Debt Level: 6576 has more cash than its total debt.
Reducing Debt: 6576's debt to equity ratio has increased from 0% to 20% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6576 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6576 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 2.6% each year.